Valuation: BOIRON

Market Cap 472M 544M 442M 405M 764M 51.84B 774M 5.17B 2.03B 25.9B 2.04B 2B 86.21B P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 424M 489M 397M 364M 686M 46.59B 695M 4.65B 1.82B 23.28B 1.84B 1.8B 77.47B EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 day-1.28%
1 week+0.74%
Current month+0.74%
1 month-4.58%
3 months-1.81%
6 months-6.87%
Current year-9.06%
1 week 26.9
Extreme 26.9
27.4
1 month 26.2
Extreme 26.2
27.4
Current year 24.6
Extreme 24.6
30.25
1 year 20.65
Extreme 20.65
31.35
3 years 20.65
Extreme 20.65
56.6
5 years 20.65
Extreme 20.65
56.6
10 years 20.65
Extreme 20.65
92.52
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2025
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Chairman 65 01/07/2011
Director/Board Member 54 10/03/2010
Director/Board Member 51 23/05/2013
Change 5-day change 1-year change 3-year change Capi.($)
-1.09%+0.74% - - 551M
-0.41%-2.31%-9.77%-6.39% 13.45B
-0.74%+0.09%+4.26%+7.27% 5.13B
-1.00%-4.06%-32.76%-54.85% 5.09B
-1.09%-2.75%-0.61%-33.98% 4.07B
-1.15%-3.23%-8.42%-5.22% 3.7B
+3.32%+0.63%+0.56%+8.14% 3.58B
-1.46%-2.88%-6.35%+11.28% 3.48B
-1.47%-1.28%-16.05%-24.25% 2.45B
-1.25%-4.06%-4.44%+47.93% 1.87B
Average -0.65%-3.02%-8.18%-5.56% 4.76B
Weighted average by Cap. -0.53%-3.32%-8.82%-9.03%

Financials

2024 2025
Net sales 488M 562M 457M 418M 788M 53.52B 799M 5.34B 2.1B 26.74B 2.11B 2.06B 89B 501M 577M 469M 429M 810M 55.01B 821M 5.49B 2.15B 27.48B 2.17B 2.12B 91.48B
Net income 11.34M 13.06M 10.61M 9.71M 18.33M 1.24B 18.57M 124M 48.74M 622M 49.05M 47.98M 2.07B 32.64M 37.62M 30.57M 27.96M 52.79M 3.58B 53.47M 358M 140M 1.79B 141M 138M 5.96B
Net Debt -49.74M -57.32M -46.57M -42.6M -80.43M -5.46B -81.48M -545M -214M -2.73B -215M -211M -9.08B -47.86M -55.15M -44.81M -40.99M -77.38M -5.25B -78.39M -524M -206M -2.62B -207M -203M -8.74B
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
2,499
Date Price Change
06/08/26 27.10 -1.09%
05/08/26 €27.40 0.00%
04/08/26 €27.40 +1.48%
03/08/26 €27.00 +0.37%
31/07/26 €26.90 -0.37%

Annual profits - Rate of surprise